Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Karyopharm Therapeutics Inc. - Common Stock
(NQ:
KPTI
)
7.670
-1.230 (-13.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
997,949
Open
8.800
Bid (Size)
7.700 (400)
Ask (Size)
7.900 (1,000)
Prev. Close
8.900
Today's Range
7.500 - 9.085
52wk Range
3.650 - 10.99
Shares Outstanding
114,010,448
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Performance
YTD
+6.7%
+6.7%
1 Month
-9.2%
-9.2%
3 Month
-14.2%
-14.2%
6 Month
+39.5%
+39.5%
1 Year
+58.1%
+58.1%
Frequently Asked Questions
Is Karyopharm Therapeutics Inc. - Common Stock publicly traded?
Yes, Karyopharm Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Karyopharm Therapeutics Inc. - Common Stock trade on?
Karyopharm Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Karyopharm Therapeutics Inc. - Common Stock?
The ticker symbol for Karyopharm Therapeutics Inc. - Common Stock is KPTI on the Nasdaq Stock Market
What is the current price of Karyopharm Therapeutics Inc. - Common Stock?
The current price of Karyopharm Therapeutics Inc. - Common Stock is 7.670
When was Karyopharm Therapeutics Inc. - Common Stock last traded?
The last trade of Karyopharm Therapeutics Inc. - Common Stock was at 05/15/26 04:00 PM ET
What is the market capitalization of Karyopharm Therapeutics Inc. - Common Stock?
The market capitalization of Karyopharm Therapeutics Inc. - Common Stock is 874.46M
How many shares of Karyopharm Therapeutics Inc. - Common Stock are outstanding?
Karyopharm Therapeutics Inc. - Common Stock has 874M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.